FLGT FY2025 SEC EDGAR DEF 14A #22 of 31 in industry

Fulgent Genetics, Inc. CEO pay ratio

The CEO earned $6.2M in FY2025 against median worker pay of $67,465 · Health Services.

Health Services peers All rankings
State
DE
Filing date
2026-03-31
Industry
Health Services
Industry rank
#22/31

Data updated August 2026

Subscribe to Fulgent Genetics, Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
92:1
Moderate (Scale: 0–1000:1)
CEO pay
$6.2M
Median worker
$67,465

Answer first

Fulgent Genetics, Inc.'s FY2025 CEO total of $6.2M ranks #834 of 1,423 complete filings; its 92:1 pay ratio ranks #686. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $67,465. Industry placement uses the FY2025 SIC-80 peer cohort (# 22 of 31, 32nd percentile - below the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Health Services companies.

Dollar rank
#834
$6.2M of 1,423 FY2025
Ratio rank
#686
92:1 of 1,423
Industry pct
32nd
below the industry median pay ratio

How Fulgent Genetics, Inc. ranks nationally

Fulgent Genetics, Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$6,206,780 41st percentile higher than 41% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). This entry sits in this band. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Fulgent Genetics, Inc. vs. Health Services peers

CEO total pay ($6.2M) against pay ratio (92:1) for Fulgent Genetics, Inc. (marked) and its 3 closest same-industry peers, against the Health Services industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both3404232.35196911.669895918782270.310574949.790.2:1100.3:1110.5:1120.7:1130.8:1CEO total payPay ratio (CEO : median worker)Fulgent Genetics, Inc., CEO total pay: 6206780 · Pay ratio (CEO : median worker): 92:1Fulgent Genetics, Inc.Pennant Group, Inc., CEO total pay: 3730174 · Pay ratio (CEO : median worker): 98:1Pennant Group, Inc.Ardent Health, Inc., CEO total pay: 6064974 · Pay ratio (CEO : median worker): 107:1Ardent Health, Inc.Surgery Partners, Inc., CEO total pay: 6083862 · Pay ratio (CEO : median worker): 112:1Surgery Partners, Inc.
Fulgent Genetics, Inc. vs. Health Services peers, plotted against the industry's $10.2M median CEO total and 129:1 median pay ratio.

Ratio bands among Health Services peers

Exclusive CEO-to-median-worker bands across 29 complete latest-FY filings in SIC 80. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Fulgent Genetics, Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Fulgent Genetics, Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2022–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
92:1
FY2025
vs prior FY
0:1
from FY2024 92:1
CEO $ YoY
+1.6%
$6.2M latest
Filings shown
4
FY2022–2025
Fulgent Genetics, Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2022 $5.2M - $68,452 76:1 -
2023 $5.3M +2% $63,924 83:1 +7:1
2024 $6.1M +15% $66,428 92:1 +9:1
2025 $6.2M +1.6% $67,465 92:1 0:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1674930, FY2022–2025. Adjacent-year deltas only.

Industry Comparison - Health Services

This Company's Ratio
92:1
Industry Median Ratio
129:1
Industry Median CEO Pay
$10.2M
This CEO's Pay
$6.2M
Companies in Industry
31
vs. Industry Median
Below
#22 of 31 by pay ratio in this industry View all companies in Health Services →

Fulgent Genetics, Inc.: MID · HEAVY pay ratio

Fulgent Genetics, Inc.'s FY2025 ratio 92:1 ranks #22 of 31 Health Services filers (32nd percentile). the CEO earned 92× the median employee ($67,465) in FY2025.

Median employee $67,465 (PAR-MED); MID · HEAVY stamps put about 92 median-wage years per CEO year.

CEO Total Pay

$6.2M

FY2025 Summary Compensation, below median

Pay Ratio

92:1

Near industry median

Fulgent Genetics, Inc. in the lower Health Services third

Fulgent Genetics, Inc.'s FY2025 ratio 92:1 ranks #22 of 31 Health Services filers (32nd percentile). The structured pay-ratio disclosure reports the total without line-item components. Health Services (SIC 80) median ratio is 129:1 across 31 FY2025 filers; Fulgent Genetics, Inc.'s $6.2M CEO total is at or below the $10.2M industry median CEO pay.

Dollar rank #834 and ratio rank #686 split - treat 92:1 as a disclosure, not a fairness score. Open Health Services peers.

Key Data, FY2025

Total Compensation
$6.2M
Median Employee Pay
$67,465
Pay Ratio
92:1
Filing Date
2026-03-31

Company Info

Ticker
FLGT
CIK
1674930
Industry
Health Services
SIC Code
8071
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 1674930, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Fulgent Genetics, Inc.'s FY2025 ratio 92:1 ranks #22 of 31 Health Services filers (32nd percentile).

Read with Fulgent Genetics, Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MID · HEAVY · PAR-MED.

United Community Banks Inc · HEAVY

ABS(ceo_total_comp) peer at $6.2M (Δ $140 heavier vs Fulgent Genetics, Inc.); MID · PAR-MED vs this page's MID · HEAVY · PAR-MED.
IES Holdings, Inc. · HEAVY

ABS(ceo_total_comp) peer at $6.2M (Δ $3K lighter vs Fulgent Genetics, Inc.); MID · PAR-MED vs this page's MID · HEAVY · PAR-MED.
Bel Fuse Inc /nj · HEAVY

ABS(ceo_total_comp) peer at $6.2M (Δ $5K heavier vs Fulgent Genetics, Inc.); EXTREME · LOW-MED vs this page's MID · HEAVY · PAR-MED.
W&t Offshore Inc · HEAVY

ABS(ceo_total_comp) peer at $6.2M (Δ $24K lighter vs Fulgent Genetics, Inc.); MODEST · ELITE-MED vs this page's MID · HEAVY · PAR-MED.
Pennant Group, Inc. (SIC 80 pole)

Pennant Group, Inc. stamps MID · MID$ nearest in-SIC by ABS(pay_ratio) to Fulgent Genetics, Inc.'s MID filing.
National dual ranks · #834/#686

Fulgent Genetics, Inc.'s FY2025 package sits #834 by CEO dollars and #686 by ratio under HEAVY · MID.
Comp structure · HEAVY

Fulgent Genetics, Inc.'s HEAVY CEO total is equity-sensitive - read what grant-date fair value does and does not mean.
Data sourced from SEC EDGAR DEF 14A for Fulgent Genetics, Inc. (CIK 1674930), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.